MediPharm Labs Completes Its First High THC Cannabis Oil Export to Peru
-- MediPharm Labs' high THC medical cannabis has been successfully exported to Peru for distribution by specialized compounding pharmacies -- Peru marks MediPharm Labs' first Latin American export following successful exports to Australia and Germany
BARRIE, Ontario, April 08, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company"), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary, MediPharm Labs Inc., completed its first shipment of premium, formulated cannabis oil to its customer Cann Farm Peru S.A.C., a Lima-based producer and distributor serving Peruvian and other markets in Latin America.
"This first import into Peru demonstrates the versatility of our GMP certified platform that qualifies MediPharm Labs to export high THC and CBD formulated oils into international medical markets where cannabis is regulated like other pharmaceutical products," said Keith Strachan, President and Interim Chief Executive Officer, MediPharm Labs. "We look forward to expanding our presence in Peru and other Latin American markets like Brazil where we have agreements in place and are awaiting final permits to import our pharmaceutical quality products to patients and physicians looking for products they can trust."
MediPharm Labs pre-formulated cannabis concentrate will be distributed to patients through compounding pharmacies in Peru that will complete final formulation and fill to exact prescription specification.
"Since Peru's initial cannabis legalization, patients have predominantly had accessed to CBD in the absence of a steady supply of legal THC. This initial shipment will provide Peru's growing patient base with access to formulated THC medicines that have a high degree of quality and control. Bringing high-quality THC into the country will also open many doors in the healthcare sector," says Andrs Vazquez, President of Cann Farm. "Providing a consistent supply of high-quality THC will allow physicians to prescribe cannabis oils to address a wider range of therapeutic needs, versus mainly CBD dominant oils, including pain management."